Impact of immunosuppressive medication on the risk of renal allograft failure due to recurrent glomerulonephritis

American Journal of Transplantation

Volumn 9, Issue 4, 2009, Pages 804-811

  Mulay, A V ^a   Van Walraven, C ^b   Knoll, G A ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Azathioprine; Cyclosporine; Graft survival; Kidney transplantation; Mycophenolate mofetil; Recurrent glomerulonephritis; Tacrolimus

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ADULT; ARTICLE; DRUG EFFECT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HAZARD RATIO; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY ALLOGRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR;

ADULT; AZATHIOPRINE; CYCLOSPORINE; FEMALE; GLOMERULONEPHRITIS; HEPATITIS B SURFACE ANTIGENS; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MARKOV CHAINS; MIDDLE AGED; MONTE CARLO METHOD; MYCOPHENOLIC ACID; RECURRENCE; RISK FACTORS; TACROLIMUS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT FAILURE;

EID: 63349097178     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02554.x     Document Type: Article

References (38)

1. 2006 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1996-2005. Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD. 2008.
2. Choy Y, Chan TM, Lai KN. Recurrent glomerulonephritis after kidney transplantation. Am J Transplant 2006 6 : 2535 2542.
3. Hariharan S, Adams MB, Brennan DC et al. Recurrent and de novo glomerular disease after renal transplantation: A report from Renal Allograft Disease Registry (RADR). Transplantation 1999 68 : 635 641.
4. Briganti EM, Russ GR, McNeil JJ, Atkins RC, Chadban SJ. Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med 2002 347 : 103 109.
5. Takemoto SK. Maintenance immunosuppression. Clin Transpl 2001 : 223 236.
6. Segarra A, Vila J, Pou L et al. Combined therapy of tacrolimus and corticosteroids in cyclosporin-resistant or -dependent idiopathic focal glomerulosclerosis: A preliminary uncontrolled study with prospective follow-up. Nephrol Dial Transplant 2002 17 : 655 662.
7. Duncan N, Dhaygude A, Owen J et al. Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy. Nephrol Dial Transplant 2004 19 : 3062 3067.
8. Szeto CC, Leung CB, Lai FM, Li PK. Tacrolimus in resistant primary membranous nephropathy-a report of 3 cases. Clin Nephrol 2003 59 : 293 296.
9. Mok CC, Tong KH, To CH, Siu YP, Au TC. Tacrolimus for induction therapy of diffuse proliferative lupus nephritis: An open-labeled pilot study. Kidney Int 2005 68 : 813 817.
10. Miller G, Zimmerman R III., Radhakrishnan J, Appel G. Use of mycophenolate mofetil in resistant membranous nephropathy. Am J Kidney Dis 2000 36 : 250 256.
11. Choi MJ, Eustace JA, Gimenez LF et al. Mycophenolate mofetil treatment for primary glomerular diseases. Kidney Int 2002 61 : 1098 1114.
12. Day CJ, Cockwell P, Lipkin GW, Savage CO, Howie AJ, Adu D. Mycophenolate mofetil in the treatment of resistant idiopathic nephrotic syndrome. Nephrol Dial Transplant 2002 17 : 2011 2013.
13. Haas M, Bohmig GA, Leko-Mohr Z et al. Peri-operative immunoadsorption in sensitized renal transplant recipients. Nephrol Dial Transplant 2002 17 : 1503 1508.
14. Birk PE, Matas AJ, Gillingham KJ, Mauer SM, Najarian JS, Chavers BM. Risk factors for chronic rejection in pediatric renal transplant recipients-a single-center experience. Pediatr Nephrol 1997 11 : 395 398.
15. Allison PD. Missing Data. (Sage University Papers Series on Quantitive Applications in the Social Sciences, series no. 07-136). Thousand Oaks, CA : Sage, 2001.
16. Freedman BI, Graves JW, Burkart JM et al. The impact of different immunosuppressant regimens on recurrent glomerulonephritis. Transplant Proc 1989 21 : 2121 2122.
17. Knoll GA, MacDonald I, Khan A, van Walraven C. Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation. J Am Soc Nephrol 2003 14 : 2381 2386.
18. Pelletier RP, Akin B, Henry ML et al. The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation. Clin Transplant 2003 17 : 200 205.
19. Bunnapradist S, Lentine KL, Burroughs TE et al. Mycophenolate mofetil dose reductions and discontinuations after gastrointestinal complications are associated with renal transplant graft failure. Transplantation 2006 82 : 102 107.
20. Gjertson DW. Impact of delayed graft function and acute rejection on kidney graft survival. Clin Transpl 2000 : 467 480.
21. Gjertson DW, Cecka JM. Determinants of long-term survival of pediatric kidney grafts reported to the United Network for organ sharing kidney transplant registry. Pediatr Transplant 2001 5 : 5 15.
22. Morris PJ, Johnson RJ, Fuggle SV, Belger MA, Briggs JD. Analysis of factors that affect outcome of primary cadaveric renal transplantation in the UK. HLA task force of the kidney advisory group of the United Kingdom Transplant Support Service Authority (UKTSSA). Lancet 1999 354 : 1147 1152.
23. Campistol JM, Romero R, Paul J, Gutierrez-Dalmau A. Epidemiology of arterial hypertension in renal transplant patients: Changes over the last decade. Nephrol Dial Transplant 2004 19 (Suppl 3 iii62 iii66.
24. Kasiske BL, Anjum S, Shah R et al. Hypertension after kidney transplantation. Am J Kidney Dis 2004 43 : 1071 1081.
25. Cosio FG, Pesavento TE, Pelletier RP et al. Patient survival after renal transplantation III: The effects of statins. Am J Kidney Dis 2002 40 : 638 643.
26. Prasad GV, Ahmed A, Nash MM, Zaltzman JS. Blood pressure reduction with HMG-CoA reductase inhibitors in renal transplant recipients. Kidney Int 2003 63 : 360 364.
27. Christensen M, Su AW, Snyder RW, Greco A, Lipschutz JH, Madaio MP. Simvastatin protection against acute immune-mediated glomerulonephritis in mice. Kidney Int 2006 69 : 457 463.
28. Ozsoy RC, Koopman MG, Kastelein JJ, Arisz L. The acute effect of atorvastatin on proteinuria in patients with chronic glomerulonephritis. Clin Nephrol 2005 63 : 245 249.
29. Nakamura T, Ushiyama C, Hirokawa K et al. Effect of cerivastatin on proteinuria and urinary podocytes in patients with chronic glomerulonephritis. Nephrol Dial Transplant 2002 17 : 798 802.
30. Kano K, Nishikura K, Yamada Y, Arisaka O. Effect of fluvastatin and dipyridamole on proteinuria and renal function in childhood IgA nephropathy with mild histological findings and moderate proteinuria. Clin Nephrol 2003 60 : 85 89.
31. Rayner BL, Byrne MJ, van Zyl SR. A prospective clinical trial comparing the treatment of idiopathic membranous nephropathy and nephrotic syndrome with simvastatin and diet, versus diet alone. Clin Nephrol 1996 46 : 219 224.
32. Sandhu S, Wiebe N, Fried LF, Tonelli M. Statins for improving renal outcomes: A meta-analysis. J Am Soc Nephrol 2006 17 : 2006 2016.
33. Perico N, Cattaneo D, Sayegh MH, Remuzzi G. Delayed graft function in kidney transplantation. Lancet 2004 364 : 1814 1827.
34. Geddes CC, Woo YM, Jardine AG. The impact of delayed graft function on the long-term outcome of renal transplantation. J Nephrol 2002 15 : 17 21.
35. Halloran PF, Homik J, Goes N et al. The "injury response": A concept linking nonspecific injury, acute rejection, and long-term transplant outcomes. Transplant Proc 1997 29 : 79 81.
36. Chertow GM, Milford EL, Mackenzie HS, Brenner BM. Antigen-independent determinants of cadaveric kidney transplant failure. JAMA 1996 276 : 1732 1736.
37. Su X, Zenios SA, Chakkera H, Milford EL, Chertow GM. Diminishing significance of HLA matching in kidney transplantation. Am J Transplant 2004 4 : 1501 1508.
38. Cibrik DM, Kaplan B, Campbell DA, Meier-Kriesche HU. Renal allograft survival in transplant recipients with focal segmental glomerulosclerosis. Am J Transplant 2003 3 : 64 67.